Literature DB >> 15556871

An Mll-dependent Hox program drives hematopoietic progenitor expansion.

Patricia Ernst1, Meghann Mabon, Alan J Davidson, Leonard I Zon, Stanley J Korsmeyer.   

Abstract

Chromosomal translocations disrupting the Mixed lineage leukemia (Mll) gene result in leukemia, with aberrant expression of some native Mll target genes (reviewed in). The Mll gene encodes a Trithorax-group chromatin regulator that is essential for the development of hematopoietic stem cells (HSCs) during embryogenesis. Like Trithorax, MLL positively regulates clustered homeodomain or Hox genes, yet the role of Hox genes collectively in the development of the mammalian hematopoietic system has been difficult to ascertain because of redundancy among Hox paralogs. Here, we show that in the absence of MLL, early hematopoietic progenitors develop despite reduced expression of HoxA, HoxB, and HoxC genes. However, these progenitors exhibit a marked reduction in their ability to generate hematopoietic colonies, a subsequent process requiring cell division and differentiation. Reactivation of a subset of Hox genes or, remarkably, reexpression of a single Hox gene in Mll-deficient progenitors rescued hematopoietic-colony frequency and growth. In contrast, expression of other MLL target genes such as Pitx2 or expression of anti-apoptotic BCL-2 failed to rescue hematopoietic-colony frequency. Furthermore, our results highlight a shared function of Hox proteins at this point in the development of the hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556871     DOI: 10.1016/j.cub.2004.11.012

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  82 in total

1.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

2.  Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.

Authors:  Imran Hussain; Arunoday Bhan; Khairul I Ansari; Paromita Deb; Samara A M Bobzean; Linda I Perrotti; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-02-25

Review 3.  Roles of a trithorax group gene, MLL, in hematopoiesis.

Authors:  Ryoichi Ono; Tetsuya Nosaka; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

4.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

Authors:  Victoria Del Gaizo Moore; Jennifer R Brown; Michael Certo; Tara M Love; Carl D Novina; Anthony Letai
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  The homeobox gene Hhex regulates the earliest stages of definitive hematopoiesis.

Authors:  Helicia Paz; Maureen R Lynch; Clifford W Bogue; Judith C Gasson
Journal:  Blood       Date:  2010-05-14       Impact factor: 22.113

6.  HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment.

Authors:  Khairul I Ansari; Imran Hussain; Bishakha Shrestha; Sahba Kasiri; Subhrangsu S Mandal
Journal:  J Mol Biol       Date:  2011-06-12       Impact factor: 5.469

7.  β-Catenin activates the HOXA10 and CDX4 genes in myeloid progenitor cells.

Authors:  Ling Bei; Chirag Shah; Hao Wang; Weiqi Huang; Rupali Roy; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 8.  Molecular pathogenesis of MLL-associated leukemias.

Authors:  Mariko Eguchi; Minenori Eguchi-Ishimae; Mel Greaves
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

9.  Elongation factor ELL (Eleven-Nineteen Lysine-rich Leukemia) acts as a transcription factor for direct thrombospondin-1 regulation.

Authors:  Jiangang Zhou; Xi Feng; Bin Ban; Jingxia Liu; Zhou Wang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

10.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.

Authors:  Relja Popovic; Laurie E Riesbeck; Chinavenmeni S Velu; Aditya Chaubey; Jiwang Zhang; Nicholas J Achille; Frank E Erfurth; Katherine Eaton; Jun Lu; H Leighton Grimes; Jianjun Chen; Janet D Rowley; Nancy J Zeleznik-Le
Journal:  Blood       Date:  2009-02-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.